| 2026-08-11 | 8-K | Form 8-K, Item 5.02 |
| 2026-07-28 | 8-K | Form 8-K, Item 2.02 results |
| 2026-07-28 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-07-28 | Transcript | Q2 FY26 earnings call transcript |
| 2026-07-22 | 8-K | Form 8-K/A, Item 7.01 |
| 2026-07-20 | Press release | NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS |
| 2026-07-20 | 8-K | Form 8-K, Item 7.01 |
| 2026-07-07 | Press release | NeoGenomics to Report Second Quarter 2026 Financial Results on |
| 2026-06-25 | Press release | NeoGenomics Appoints Carolyn Starrett to its Board of Directors |
| 2026-06-25 | 8-K | Form 8-K, Item 5.02 |
| 2026-06-22 | 8-K | Form 8-K, Item 1.01 |
| 2026-06-17 | 8-K | Form 8-K, Item 8.01 |
| 2026-06-15 | 8-K | Form 8-K, Item 8.01 |
| 2026-05-26 | Press release | Download as PDF |
| 2026-05-22 | 8-K | Form 8-K, Item 5.02 |
| 2026-05-15 | Press release | NeoGenomics to Participate in Upcoming Investor Conferences |
| 2026-05-15 | Press release | Download as PDF |
| 2026-04-28 | Press release | NeoGenomics Reports First Quarter 2026 Results |
| 2026-04-28 | Press release | Download as PDF · Q1 2026 |
| 2026-04-28 | Deck | Investor presentation · Q1 2026 · Apr 2026 |
| 2026-04-28 | 8-K | Form 8-K, Item 2.02 results |
| 2026-04-28 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-04-07 | Press release | NeoGenomics to Report First Quarter 2026 Financial Results on |
| 2026-04-06 | Proxy | Definitive proxy statement |
| 2026-03-10 | Deck | NeoGenomics Investor Presentation – March 2026 |
| 2026-02-17 | Deck | NeoGenomics Investor Presentation – February 2026 |
| 2026-02-17 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-17 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-01-27 | Press release | NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 |
| 2026-01-12 | 8-K | Form 8-K, Item 2.02 results |
| 2026-01-10 | Deck | NeoGenomics at JP Morgan Healthcare Conference 2026 |
| 2025-12-30 | 8-K | Form 8-K, Item 5.02 |
| 2025-10-28 | Deck | Investor presentation · Q3 2025 · Oct 2025 |
| 2025-10-28 | 8-K | Form 8-K, Item 2.02 results |
| 2025-10-28 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
| 2025-10-14 | Press release | NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025 |
| 2025-08-08 | 8-K | Form 8-K, Item 5.02 |
| 2025-07-29 | Deck | Investor presentation · Q2 2025 · Jul 2025 |
| 2025-07-29 | 8-K | Form 8-K, Item 2.02 results |
| 2025-07-29 | 10-Q | Form 10-Q for the quarter ended Jun 30 |